movano is a health-focused technology company that believes glucose is an important health metric to continuously track, as glucose levels serve as a proxy for metabolic health and risk for chronic disease, such as diabetes. we also believe that whether you are a person with diabetes, prediabetes or someone looking to pursue a healthier lifestyle, monitoring and managing your glucose levels shouldn’t be painful, complicated or conspicuous.
Company profile
Ticker
MOVE
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
Maestro Sensors Inc.
SEC CIK
Corporate docs
Subsidiaries
Movano Ireland Limited ...
IRS number
824233771
MOVE stock data
Latest filings (excl ownership)
S-3
Shelf registration
23 Apr 24
D
$24.13 mm in equity / options, sold $24.13 mm, 185 investors
17 Apr 24
10-K
2023 FY
Annual report
16 Apr 24
8-K
Movano Health Reports 2023 Financial Results and Provides Business Update
4 Apr 24
8-K
Entry into a Material Definitive Agreement
3 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement
29 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Nov 23
424B5
Prospectus supplement for primary offering
16 Nov 23
8-K
Movano Health Announces Proposed Public Offering
15 Nov 23
Transcripts
MOVE
Earnings call transcript
2023 Q4
4 Apr 24
MOVE
Earnings call transcript
2023 Q3
15 Nov 23
MOVE
Earnings call transcript
2023 Q2
14 Aug 23
MOVE
Earnings call transcript
2023 Q1
15 May 23
MOVE
Earnings call transcript
2022 Q4
20 Mar 23
MOVE
Earnings call transcript
2022 Q3
15 Nov 22
MOVE
Earnings call transcript
2022 Q2
16 Aug 22
MOVE
Earnings call transcript
2022 Q1
15 May 22
MOVE
Earnings call transcript
2021 Q3
11 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.67 mm | 7.67 mm | 7.67 mm | 7.67 mm | 7.67 mm | 7.67 mm |
Cash burn (monthly) | 2.27 mm | 689.67 k | 3.03 mm | 2.64 mm | 2.32 mm | 2.27 mm |
Cash used (since last report) | 15.55 mm | 4.73 mm | 20.76 mm | 18.11 mm | 15.92 mm | 15.57 mm |
Cash remaining | -7.88 mm | 2.94 mm | -13.09 mm | -10.44 mm | -8.25 mm | -7.90 mm |
Runway (months of cash) | -3.5 | 4.3 | -4.3 | -4.0 | -3.6 | -3.5 |
Institutional ownership, Q3 2023
12.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 24 |
Opened positions | 4 |
Closed positions | 2 |
Increased positions | 7 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 9.57 bn |
Total shares | 12.52 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Dorsey & Whitney Trust | 3.75 mm | $4.09 bn |
Tamkin Gregory S | 3.75 mm | $14.27 mm |
Vanguard | 1.80 mm | $1.96 bn |
AWM Investment | 1.36 mm | $1.49 bn |
Raymond James Financial Services Advisors | 535.80 k | $584.02 mm |
Mirador Capital Partners | 369.43 k | $402.68 mm |
Geode Capital Management | 328.23 k | $357.88 mm |
Baird Financial | 302.00 k | $329.18 mm |
BLK Blackrock | 96.66 k | $105.36 mm |
NTRS Northern Trust | 51.94 k | $56.62 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Apr 24 | Jeremy Cogan | Common Stock | Buy | Acquire P | No | No | 0 | 45,000 | 0.00 | 780,649 |
2 Apr 24 | Jeremy Cogan | Warrant to Purchase Common Stock Common Stock | Buy | Acquire P | No | No | 0.44 | 45,000 | 19.80 k | 45,000 |
2 Apr 24 | Brian Cullinan | Common Stock | Buy | Acquire P | No | No | 0 | 44,000 | 0.00 | 260,070 |
2 Apr 24 | Brian Cullinan | Warrant to Purchase Common Stock Common Stock | Buy | Acquire P | No | No | 0.44 | 44,000 | 19.36 k | 44,000 |
2 Apr 24 | Emily Fairbairn | Common Stock | Buy | Acquire P | Yes | No | 0 | 4,690,000 | 0.00 | 4,985,000 |
2 Apr 24 | Emily Fairbairn | Warrant to Purchase Common Stock Common Stock | Buy | Acquire P | Yes | No | 0.4071 | 4,690,000 | 1.91 mm | 4,690,000 |
2 Apr 24 | John Mastrototaro | Common Stock | Buy | Acquire P | No | No | 0 | 176,500 | 0.00 | 291,642 |
2 Apr 24 | John Mastrototaro | Warrant to Purchase Common Stock Common Stock | Buy | Acquire P | No | No | 0.44 | 176,500 | 77.66 k | 176,500 |
2 Apr 24 | Caballero Ruben | Common Stock | Buy | Acquire P | No | No | 0 | 22,000 | 0.00 | 80,200 |
2 Apr 24 | Caballero Ruben | Warrant to Purchase Common Stock Common Stock | Buy | Acquire P | No | No | 0.44 | 22,000 | 9.68 k | 22,000 |
News
12 Information Technology Stocks Moving In Friday's Pre-Market Session
19 Apr 24
12 Information Technology Stocks Moving In Monday's After-Market Session
15 Apr 24
12 Information Technology Stocks Moving In Monday's Pre-Market Session
8 Apr 24
Kura Sushi, Greenbrier And 3 Stocks To Watch Heading Into Friday
5 Apr 24
Movano Says Focuses On 2024 Strategic Pathway To FDA Clearances Driving B2B Opportunities; Executes $24M Funding Extending Cash Runway
4 Apr 24
Press releases
Movano Health Closes $24 Million Private Placement
5 Apr 24
Movano Health Reports 2023 Financial Results and Provides Business Update
4 Apr 24
Movano Health Reports 2023 Financial Results and Provides Business Update
4 Apr 24
BestGrowthStocks.Com Issues Comprehensive Evaluation of Movano Inc.
3 Apr 24
Movano Health Announces $24 Million Private Placement
2 Apr 24